Last reviewed · How we verify
Placebo (for Voltaren) — Competitive Intelligence Brief
phase 3
Pain/Inflammation (as control for Voltaren)
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo (for Voltaren) (Placebo (for Voltaren)) — Ache Laboratorios Farmaceuticos S.A.. A placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo (for Voltaren) TARGET | Placebo (for Voltaren) | Ache Laboratorios Farmaceuticos S.A. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo (for Voltaren) CI watch — RSS
- Placebo (for Voltaren) CI watch — Atom
- Placebo (for Voltaren) CI watch — JSON
- Placebo (for Voltaren) alone — RSS
Cite this brief
Drug Landscape (2026). Placebo (for Voltaren) — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-for-voltaren. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab